MindRank rises through the ranks with $52m Series B for oral GLP-1 The $52 million Series B capital will be used to advance AI-native drug discovery engine and Phase III GLP-1 candidate
YesPlexusDx compounded semaglutide injections are shipped from licensed 503A compounding pharmacies with insulated, temperature-controlled packaging to maintain the cold chain during delivery
Research Use Limitation Used solely for laboratory and in vitro research Not approved for human consumption Not approved for veterinary use Not intended for diagnostic purposes Not intended for therapeutic applications Not permitted for clinical administration For research use only Independently analysed by Liquilabs s.r.o
1/1 Since:2009-09-15 Address:Room 307 A, Baoshan District, Shanghai, China, 3rd Floor, No.248 Dongxin Road, Putuo District, Shan Name:Tirzepatide Other name:Mounjaro CAS:2023788-19-2 EINECS:N/A Molecular formula:C225H348N48O68 Molecular weight:4813.45 Melting point:N/A Purity:98% Applications:organic intermediate Appearance:White powder Package:15mg, 30mg, 60mg per vial, or bulk package -